People winge all the time at Co's directors for not buying on...

First 3 Last

Share
Profile

Follow
wgdt72

3,054 Posts.

147

01/05/18

22:06

Post #: 32813089
Share

Originally posted by Lefevre ↑

Looks like the Directors are the only buyers currently.
They have been buying all the way down from mid 20's.

The company is kicking goals and moving forward at great knots.

Revenue guidance for this 30 June Financial year has been confirmed and they have conservatively estimated 60% growth next financial year based on existing contracts. No new deals are taken into account.

Ralph has only recently come on board as the CEO and he has an amazing track record. He took a pay cut to join Sensera but he believes he will be ultimately rewarded through his options package which is currently way out of the money.

Ralph has restructured the operations of the business and has brought in his own people. He is extremely excited about the prospects of the Nanotron business. The smartbow deal is only just the beginning and that is a major deal for a small IOT company to snag.

I am backing Ralph and MM for the billion dollar exit. Given Sensera's revenues and long term sticky significant $ contracts in place , the current $30 mil market cap is a joke.

I am more confident in Sensera's prospects today than I have been since its listed and it is trading at its all time lows. This is reflective of overall market sentiment towards tech stocks listed on the ASX and their respective valuation adjustments due to ASX questioning of stocks like GSW and BIG and BUD and I believe the recent correction in FANG stocks in the USA (mainly due to the Facebook data breaches).

BUD is an IOT stock and many people think it has great prospects even at its current low valuation which is still $110 mil. Ours is $30 mil with revenues that are right now multiples of BUD's and Sensera has I feel much higher quality growth prospects in coming years with a higher quality business model.

The market is making no sense and hence the opportunity currently. Sensera cannot be ignored for much longer.

Expand

People winge all the time at Co's directors for not buying on market to support the SP out of their own pocket. Time will tell i guess but respect here for those directors buying now.

SE1 Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 3 Last

Add SE1 (ASX) to my watchlist

People winge all the time at Co's directors for not buying on...

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News